Epidemiology of community-acquired pneumonia hospitalizations and associated complications before and after the implementation of the heptavalent pneumococcal conjugate vaccine in Athens, Greece

  • Theano Lagousi
  • , Ioanna Papadatou
  • , Ioannis Kopsidas
  • , Elena Critselis
  • , Maria Theodoridou
  • , Vana Spoulou

Research output: Contribution to journalArticlepeer-review

Abstract

We determined the rates of community-acquired pneumonia (CAP)-associated hospitalizations and complications in Athens, over a period covering 4 years before and 4 years after the implementation of the 7-valent pneumococcal vaccine (PCV7) in Greece. PCV7 had no impact on pediatric CAP rates, whereas there was an increase in CAP-associated complications.

Original languageEnglish
Pages (from-to)260-263
Number of pages4
JournalJournal of the Pediatric Infectious Diseases Society
Volume4
Issue number3
DOIs
Publication statusPublished - Sept 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Children
  • Pneumococcal vaccine
  • Pneumonia

Fingerprint

Dive into the research topics of 'Epidemiology of community-acquired pneumonia hospitalizations and associated complications before and after the implementation of the heptavalent pneumococcal conjugate vaccine in Athens, Greece'. Together they form a unique fingerprint.

Cite this